Clinical Trials Logo

Clinical Trial Summary

Prosthetic Joint Infections (PJIs) are increasing with the use of orthopedic devices on an ageing population. Cutibacterium acnes is a commensal organism that plays an important role in the ecosystem healthy human skin, yet this species is also recognized as a pathogen in foreign body infection: endocarditis, prostatitis and specifically in PJIs. C. acnes is able to escape the immune system. This phenomenon could reflect two bacterial behavior: the bacterial internalization by host cells and the biofilm formation.


Clinical Trial Description

The aim of the study is to evaluate specific pathogenicity factors (ability to internalize bone cells and ability to form a biofilm) of bacteria derived from clinical strains of C. acnes isolated from bone infections on orthopedic material. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03950063
Study type Observational
Source CHU de Reims
Contact Xavier OHL
Phone 03 26 78 32 72
Email xohl@chu-reims.fr
Status Not yet recruiting
Phase
Start date June 15, 2019
Completion date June 15, 2021

See also
  Status Clinical Trial Phase
Completed NCT05919888 - SURGX Antimicrobial Gel Versus Povidone-iodine Skin Incision Prep in Total Shoulder Arthroplasty Phase 4